Zeo ScientifiX, Inc. 8-K

What Happened
Zeo ScientifiX, Inc. (ZEOX) filed an Form 8‑K (Item 8.01) on April 21, 2026, announcing it has successfully trained over 500 clinicians through its monthly Masterclass series focused on regenerative biologics treatments. The company issued a press release describing this milestone, which is included as Exhibit 99.1 to the filing.

Key Details

• Date of filing/announcement: April 21, 2026 (Form 8‑K, Item 8.01).
• Milestone: more than 500 clinicians trained through the company’s monthly Masterclass series in regenerative biologics.
• Disclosure: the press release is attached as Exhibit 99.1; the cover page iXBRL file is included as Exhibit 104.
• No financial results, new agreements, or executive changes were reported in this 8‑K.

Why It Matters
This 8‑K communicates operational progress in Zeo ScientifiX’s professional-education efforts—specifically clinician outreach and training in regenerative biologics—which the company highlights as a milestone. For investors, the filing is an update on market engagement and program traction; it does not include financial metrics, earnings, or material contractual changes.